Clinical Trial Update: A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems [Phase 1]

View source ↗

Summary

Takeda announced results from a Phase 1 study of pevonedistat in people with blood cancers and solid tumors who also have kidney or liver impairment, including …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Myelomonocytic Leukemia

Drugs mentioned

• Pevonedistat (pevonedistat)

Snippet

Sponsor: Takeda | Conditions: Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic | Phase 1 | Status: COMPLETED | Results posted: 2024-09-05